Innovating Works
AI4HF: Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure STICHTING NETHERLANDS HEART INSTITUTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage Cardiovascular diseases remain the main cause of mortality worldwide; in particular, heart failure (HF) poses complex challenges in clinical...
2023-06-01 - 2027-05-31 | Financiado
GEREMY: Gene Therapy for treatment of rare inherited Arrhythmogenic Cardiomyopathy STICHTING NETHERLANDS HEART INSTITUTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Development of a cure for rare cardiac diseases is a risky, costly and time-consuming process, which is hampered by insufficient insight int...
2023-05-01 - 2027-04-30 | Financiado
PROFID: Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardi... STICHTING NETHERLANDS HEART INSTITUTE participó en un H2020: H2020-SC1-BHC-2018-2020 Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence o...
2019-12-13 - 2024-12-31 | Financiado
CARDIATEAM: CARdiomyopathy in type 2 DIAbetes mellitus STICHTING NETHERLANDS HEART INSTITUTE participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage A rapidly evolving epidemic in Type 2 Diabetes (T2DM) is afflicting all ages, sexes and socioeconomic classes which includes serious comorbi...
2019-04-11 - 2026-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.